Philips iFR Syncvision Co-Registration 2020
Details
Organised by
Date and registration
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessArnold Seto
Arnold Seto MD MPA is the Director of Interventional Cardiology Research at University of...
Read MoreArnold Seto MD MPA is the Director of Interventional Cardiology Research at University of California, Irvine and Cath Lab Director at the Long Beach Veterans Affairs Medical Center. He was an active participant in the DEFINE-FLAIR and DEFINE-PCI trials, and a steering committee member for DEFINE-PCI. He has published multiple manuscripts in coronary artery disease, coronary physiology, and vascular access especially in the areas of accurate measurement of FFR and ultrasound guidance for radial and femoral access.
Show LessHabib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read MoreDr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show LessJose de la Torre Hernandez
Prof Jose M de la Torre is an interventional cardiologist, Head of Hemodynamics and...
Read MoreProf Jose M de la Torre is an interventional cardiologist, Head of Hemodynamics and Interventional department of the Marques de Valdecilla University of Santander, Spain. He is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. Prof De La Torre is a member of the editorial committee of the Revista Español de Cardiologia,, Consultant editor of JACC Cardiovascular interventions, Section editor in Eurointervention and Editor in chief of REC: Interventional Cardiology. Research coordinator in EPIC foundation. In 2016-2017 he was a visiting scientist at Harvard-MIT biomedical engineering center. His research interests include intravascular imaging, coronary artery disease and drug eluting stents.
Show LessMorton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read MoreDr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show LessSAYAN SEN
A consultant/attending. Features in 94 videos on Wondr Medical. SAYAN SEN generally speaks on...
Read MoreA consultant/attending. Features in 94 videos on Wondr Medical. SAYAN SEN generally speaks on Fractional Flow Reserve (FFR), Live Cases, Instantaneous wave-Free Ratio (iFR), Renal Denervation (RDN), and Catheter laboratory skills.
Show LessSukh Nijjer
Dr Sukhjinder Nijjer is a Consultant Cardiologist and Honorary Senior Clinical Lecturer at...
Read MoreDr Sukhjinder Nijjer is a Consultant Cardiologist and Honorary Senior Clinical Lecturer at Imperial College London. He is the President of Cardiology at the Royal Society of Medicine and is the Communication Lead for the British Cardiovascular Intervention Society. He works at the Hammersmith Hospital as an Interventional Cardiologist and is an expert in Coronary Physiology. His PhD research focused on the development of instantaneous wave-free ratio (iFR) pullback and co-registration. He has published over 100 original academic papers and has involved in the DEFINE-FLAIR, SYNTAX-II and ORBITA-1 and ORBITA-2 research studies.
Show Less